United States · FDA National Drug Code directory
Bloxiverz
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51754-1200_f9ddedaa-a4a1-4fa2-8a3e-a3bb3abdde47
- Product NDC
- 51754-1200
- Form
- INJECTION
- Composition / generic term
- Neostigmine Methylsulfate
- Labeler
- Exela Pharma Sciences, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20231106
- Source listing expiry
- 20261231
Source-listed ingredients
- NEOSTIGMINE METHYLSULFATE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE, PLASTIC in 1 CARTON (51754-1200-3) / 5 mL in 1 SYRINGE, PLASTIC · 51754-1200-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →